$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
转移性去势抵抗性前列腺癌:帕他色替联合阿比特龙显示出潜力
2025-10-19 11:44:20
Check Details
新型双特异性单克隆抗体对治疗mCRPC的STEAP1靶点具有临床前应用前景
2025-10-19 11:44:20
Check Details
无论PSA基线水平如何,恩杂鲁胺联合ADT可改善转移性激素敏感型前列腺癌的rPFS
2025-10-19 11:44:20
Check Details
Nubeqa治疗非转移性去势抵抗性前列腺癌获NICE推荐
2025-10-19 11:44:20
Check Details
在存在DNA修复基因异常的晚期前列腺癌患者中,铂类治疗有抗肿瘤活性
2025-10-19 11:44:20
Check Details
基于先进分子成像的治疗可以改善前列腺癌的DFS
2025-10-19 11:44:20
Check Details
康士得多久出现耐药性?
2025-10-19 11:44:20
Check Details
恩杂鲁胺是哪国的?
2025-10-19 11:44:20
Check Details
恩杂鲁胺什么时候吃效果好?
2025-10-19 11:44:20
Check Details
恩杂鲁胺饭前吃还是饭后吃?
2025-10-19 11:44:20
Check Details
康士得服用多久见效?
2025-10-19 11:44:20
Check Details
康士得是干嘛用的?
2025-10-19 11:44:20
Check Details
1
2
...
1487
1488
1489
1490
1491
1492
1493
...
4158
4159
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
2
Lapatinib: Proper Administration Guide and Key Precautions
3
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
4
Cemiplimab Storage and Handling Guide
5
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Dosing Duration, Efficacy Comparison, and Long-Term Management
6
Belzutifan (Welireg): Comprehensive Guide to the First HIF-2α Inhibitor — Indications, Dosing, and Safety Monitoring
7
Encorafenib (Braftovi): Comprehensive Guide to BRAF V600 Inhibitor Indications, Dose Regimens by Tumor Type, and Administration Requirements
8
Alpelisib vs Inavolisib: How to Choose Between Two PI3Kα Inhibitors in PIK3CA-Mutated Breast Cancer
9
Selumetinib: The First MEK1/2 Inhibitor Approved for Inoperable Plexiform Neurofibromas in NF1
10
FIGHT-302 Phase 3 Trial: First-Line Pemigatinib Significantly Improves PFS Over Chemotherapy in FGFR2-Rearranged Cholangiocarcinoma
11
Selpercatinib Dosing Guide: Weight-Based Precision Targeting for RET-Driven Tumors
12
Mitotane Side Effects: Understanding Key Risks in Adrenocortical Carcinoma Therapy